A new method of computer-aided evaluation makes it easier to differentiate between benign and malignant lesions on MR scans, possibly reducing the number of false positives and unnecessary biopsies.
Other findings include:
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.